IVF Out-of-Pocket Costs: $15,000 to $30,000+

A single cycle of IVF in the United States typically costs between $15,000 and $30,000 out of pocket when you add up the clinic fee, medications, lab procedures, and monitoring. That range is wide because almost nothing about IVF pricing is standardized: the drugs your body needs, the optional genetic testing your doctor recommends, the state you live in, and the number of cycles it takes to achieve a pregnancy all push the final number in different directions. Understanding where the money actually goes, and where the biggest surprises hide, can help you plan more realistically than a single headline figure ever could.

Where the Base Cost Comes From

The sticker price most clinics advertise covers the core medical steps: ovarian stimulation monitoring, egg retrieval, fertilization in the lab, and embryo transfer. In many U.S. clinics, that advertised fee lands somewhere around $12,000 to $14,000 for one fresh cycle. But that number almost never includes the injectable hormone medications you take for roughly ten days before retrieval, which alone can run $3,000 to $7,000 depending on the protocol and your body’s response. A European cost analysis found that hormonal stimulation accounted for a large share of per-cycle costs, with the specific gonadotropin chosen making a meaningful difference in total spend.

Anesthesia for the retrieval, the lab culture of embryos, and cryopreservation (freezing) of any extra embryos are frequently billed separately. Embryo freezing and annual storage fees add a few hundred to over a thousand dollars per year. If you end up needing a frozen embryo transfer in a later cycle rather than a fresh transfer, that is another procedure with its own price tag, though it is considerably cheaper than a full stimulation cycle because you skip the drug-heavy retrieval phase.

Diagnostic Work Before You Even Start

Before a clinic begins an IVF cycle, you and your partner typically go through an infertility workup: blood hormone panels, semen analysis, transvaginal ultrasound, and often a hysterosalpingogram to check whether the fallopian tubes are open. These tests are not included in the IVF cycle fee. A 2024 study examining infertility workup pricing across the United States found that total diagnostic costs varied dramatically by state, from about $835 in Oregon to nearly $3,000 in Alaska, with the Midwest averaging the highest costs at around $1,650.¹ Those costs correlated with median household income in the region, so living in an expensive metro area tends to mean paying more for the same blood draws and imaging.

Some insurance plans cover diagnostic testing even when they exclude IVF itself, so it is worth checking your specific policy before assuming you will pay for everything out of pocket. Still, if your plan does not cover diagnostics, you could spend $1,000 to $3,000 before the IVF cycle clock even starts ticking.

Add-Ons That Push the Bill Higher

The gap between $15,000 and $30,000 (or more) often comes down to optional but commonly recommended procedures layered on top of the base cycle. Two of the most significant are preimplantation genetic testing for aneuploidy (PGT-A) and intracytoplasmic sperm injection (ICSI).

Genetic Testing of Embryos

PGT-A screens embryos for the correct number of chromosomes before transfer, aiming to select embryos most likely to implant and least likely to miscarry. A biopsy of each embryo plus the genetic lab analysis typically adds $3,000 to $6,000 per cycle. A U.S. study analyzing over 158,000 IVF cycles found that PGT-A was associated with higher costs across all age groups. For patients under 35, the testing led to worse outcomes and higher spending. For those 35 and older, it did increase cumulative birth rates but still came with higher costs.² A separate analysis of donor-egg cycles found that PGT-A added roughly $6,000 per cycle and was not cost-effective in nearly all simulated scenarios.³

This does not mean PGT-A is never worth it. For some patients, especially those with recurrent miscarriage or older maternal age, the potential to avoid a failed transfer or early pregnancy loss has real emotional and financial value. But the data suggest that for younger patients with no specific indication, the added cost may not buy better odds. Chinese data echoed a similar pattern, showing PGT-A raised per-live-birth costs by roughly 17% compared to conventional IVF.⁴

ICSI and Other Lab Procedures

ICSI, where a single sperm is injected directly into each egg, was originally developed for severe male-factor infertility. It adds roughly $1,500 to $2,500 per cycle at most U.S. clinics. Despite being designed for specific sperm-related diagnoses, ICSI is now used in a majority of IVF cycles in many countries, even when sperm quality is normal. A detailed European cost analysis found that the per-cycle cost difference between standard IVF and ICSI was modest, with costs per ongoing pregnancy roughly comparable between the two techniques.⁵ Scottish NHS data similarly showed fresh ICSI cycles costing only a few hundred pounds more than fresh IVF cycles on average.⁶ The question is not whether ICSI is expensive in isolation but whether you actually need it. When the indication is clear, the incremental cost is well justified. When it is routine, you are paying extra for a procedure that may not improve your chances.

Other lab add-ons sometimes offered include assisted hatching, time-lapse embryo imaging, and endometrial receptivity testing. Each can add several hundred to a couple thousand dollars. The evidence base for many of these is thin, and some professional societies have flagged them as unproven. Ask your clinic which add-ons they recommend and why, and whether any trial data supports the recommendation for your specific situation.

How Age Drives Cumulative Spending

The per-cycle cost is only part of the picture. What most people actually care about is the total cost to take home a baby, and that number depends heavily on how many cycles it takes. Age is the single biggest predictor. An Australian study found that the average healthcare cost per live birth from IVF was about $25,000 for women under 30 but ballooned to roughly $98,000 for women 40 and older, and reached around $183,000 for women 42 and above.⁷ A separate analysis confirmed the same steep curve, with incremental cost per live birth climbing from roughly AU$27,000–$32,000 for women in their early 30s to AU$131,000–$188,000 for women aged 42 to 45.⁸

These figures reflect the compounding effect of lower success rates per cycle. A 32-year-old might have a 40–50% chance of a live birth per transfer; a 42-year-old might have a 10–15% chance. When each cycle costs $15,000 to $20,000, the math gets brutal quickly. This is also why age-related counseling matters so much: patients who begin IVF earlier, or who consider donor eggs at a certain point, can sometimes spend less in total even though any individual decision feels harder in the moment.

The Hidden Bill for Travel, Time, and Lost Wages

Clinic fees and drug costs are at least predictable. What catches many patients off guard is the indirect spending: fuel or flights, hotel stays for those who travel to a clinic, meals eaten out during monitoring appointments, and wages lost to time off work. An Irish study that tracked these hidden costs found that patients living more than 100 miles from the clinic spent an average of €703 in indirect costs for a single cycle, compared to €104 for patients living in the same city. Travel time ranged from 15 hours total for local patients to 139 hours for those farthest away, and time off work ranged from 35 to 75 hours.⁹

In the United States, where fertility clinics cluster in major metro areas and patients in rural states often have no local option, the travel burden can be even larger. A cycle requiring eight to twelve monitoring visits in the span of two weeks means repeated trips, or temporarily relocating near the clinic. If you are a salaried employee with flexible leave, the wage hit may be minimal; if you are an hourly worker, every monitoring appointment is unpaid time. These costs rarely appear in any cost calculator but can add thousands of dollars to a cycle.

When Complications Add to the Tab

Most IVF cycles go smoothly from a medical standpoint, but ovarian hyperstimulation syndrome (OHSS) is the complication patients dread most. In moderate to severe cases, the ovaries swell and fluid accumulates in the abdomen, sometimes requiring hospitalization. Research comparing management strategies estimated that hospital-based treatment for OHSS and associated complications could cost over $10,000 per episode, while outpatient management with paracentesis brought that down to around $2,000.¹⁰ Modern protocols have reduced the incidence of severe OHSS considerably, but it remains a risk, especially for younger patients with high ovarian reserve. If your clinic uses a “freeze-all” strategy when OHSS risk is elevated, you avoid the most dangerous scenarios but still pay for the frozen embryo transfer cycle later.

Multiple pregnancies, particularly twins, also carry large downstream costs. The obstetric care, higher rate of preterm delivery, and NICU stays associated with twin pregnancies can dwarf the IVF cycle cost itself. This is a major reason why single-embryo transfer has become standard practice in many clinics despite patients’ understandable desire to transfer two embryos and improve per-cycle odds.

Insurance Coverage Is a Patchwork

Whether your insurance covers any part of IVF depends on your state, your employer, and the fine print of your plan. A handful of U.S. states mandate that insurers cover fertility treatment, but the specifics vary widely: some require coverage of IVF specifically, others mandate coverage of fertility diagnostics only, and most mandates apply only to fully insured group plans, not the self-insured plans that large employers typically use.

A cross-sectional analysis of 58 U.S. insurance companies found that only a small fraction capped coverage by cycle count, limiting patients to three or four lifetime cycles.¹¹ More commonly, plans impose either a dollar-based lifetime maximum or a cycle-based limit.¹² A plan with a $25,000 lifetime cap might cover one full cycle and part of a second, leaving you to cover the rest. A plan with a three-cycle limit might cover the clinical fees but exclude medications, or exclude PGT-A.

If you work for a large tech or finance company, you may have a fertility benefit through a third-party program such as Progyny, Carrot, or Maven. These programs often cover multiple cycles and sometimes include medication, freezing, and even some travel reimbursement. But they are employer-selected benefits, not insurance mandates, which means they can change with your job. If you are self-employed, freelance, or work for a small employer in a state without a mandate, IVF is almost always entirely out of pocket.

Mild Stimulation Protocols and Cost Savings

One way to reduce per-cycle spending is to use a milder stimulation protocol that requires fewer (and cheaper) medications. In a mild IVF cycle, lower doses of gonadotropins or oral medications like clomiphene or letrozole are used, which typically produces fewer eggs but at a lower drug cost and with a lower risk of OHSS. A randomized trial comparing mild and standard IVF strategies found that despite patients in the mild group needing more cycles on average (2.3 versus 1.7), total costs over 12 months were significantly lower: roughly €8,333 versus €10,745. The cost per live birth was also lower with the mild approach, largely because the standard protocol led to more multiple pregnancies and their associated obstetric expenses.¹³

Data on poor responders, the patients whose ovaries produce few eggs regardless of drug dose, showed a similar cost dynamic. A study of minimal stimulation IVF versus conventional IVF in poor responders found that medication costs were roughly €1,260 lower per cycle with the minimal approach.¹⁴ The minimal protocol was somewhat less effective per cycle, but the large cost savings meant it was likely cost-effective from the payer’s perspective. For patients who are paying entirely out of pocket and can tolerate the possibility of needing more retrieval attempts, mild IVF can make the financial runway longer.

Refund Programs and Financing

Many clinics and third-party companies offer “shared risk” or refund programs. The basic model: you pay a higher upfront fee (often $20,000 to $35,000) that covers multiple cycles, and if you do not take home a baby, you get a partial or full refund. The American Society for Reproductive Medicine’s Ethics Committee has described these as charging a higher initial fee in exchange for reduced fees on subsequent cycles and a refund if treatment fails.¹⁵

These programs can provide peace of mind, but they come with trade-offs. The upfront cost is higher than a single-cycle fee, so patients who succeed on the first try pay more than they would have otherwise. Programs also screen applicants, often excluding patients with poor prognoses (older age, low ovarian reserve, high BMI). That means the patients most likely to need multiple cycles are sometimes the ones who cannot qualify. And “refund” does not always mean 100% back: read the contract carefully, because some programs retain a portion for administrative costs.

Medical loans and credit lines marketed specifically for fertility treatment (such as those through Prosper Healthcare Lending or LendingClub) are another option. Interest rates vary widely and can be steep. If you are financing IVF through debt, consider total repayment cost, not just the monthly payment.

Traveling Abroad for Treatment

Reproductive tourism is a growing phenomenon driven primarily by cost. A comparative study found that IVF services in Turkey were significantly cheaper than in the United States, and even after adding travel and accommodation expenses, the total cost remained lower than U.S. treatment. The same study noted that quality indicators and success rates at the Turkish hospital examined were comparable to or better than U.S. benchmarks.¹⁶ Countries like the Czech Republic, Spain, Greece, and Mexico are popular destinations for U.S. and U.K. patients seeking lower prices or access to donor eggs with shorter wait times.

Cross-border treatment introduces its own costs and risks: coordinating care between a local doctor and an overseas clinic, navigating different regulatory frameworks for embryo handling and genetic testing, and the logistical challenge of being far from home during a medically sensitive period. If complications arise after you return, your local provider may not have full records. For patients who do their research and choose accredited clinics, the savings can be substantial, but it is not a decision to make based on price alone.

Who Gets Priced Out

The financial burden of IVF does not fall evenly. In a survey-based study of fertility patients in the United States, Black and Hispanic women were roughly twice as likely as White and Asian respondents to report income as a barrier to accessing care.¹⁷ The same study found that weight was also cited as a barrier at higher rates among Black and Hispanic women, reflecting both BMI-based clinic policies and the broader intersection of health disparities with reproductive care. A narrative review of racial disparities in fertility services noted that challenges with receiving referrals, accessing clinics, and affording treatment compound to produce worse outcomes for minority patients.¹⁸

In low- and middle-income countries, the picture is starker. A systematic review found that direct medical costs for a single IVF cycle often exceeded the national GDP per capita, making treatment unaffordable for most people. Patients facing strong social pressure to have children may pursue treatment anyway, taking on catastrophic debt. The review described infertility as a “medical and social poverty trap” in these settings.¹⁹ Economic modeling of IVF access in the United States has similarly shown that high out-of-pocket prices deter potential patients from starting treatment at all, and that those who do start face incentives to transfer multiple embryos to maximize per-cycle odds, which increases the risk of costly complications from multiple pregnancies.²⁰

Third-Party Reproduction Costs

If your treatment requires donor eggs, donor sperm, or a gestational carrier, the costs escalate well beyond a standard IVF cycle. Donor sperm is the least expensive addition, typically $500 to $1,500 per vial from a sperm bank, though you may want to purchase multiple vials for future siblings. Donor eggs are far more expensive. A fresh donor egg cycle, where a donor undergoes stimulation and retrieval specifically for you, can cost $20,000 to $40,000 or more when you factor in the donor’s compensation, her medical screening and medications, legal fees, and agency fees. Frozen donor egg banks have brought that cost down somewhat, often to $10,000 to $20,000 for a batch of eggs, but success rates with frozen donor eggs vary by bank and thaw survival rates.

Gestational surrogacy is the most expensive path, commonly running $100,000 to $200,000 in the United States when you include the carrier’s compensation, legal contracts, insurance for the carrier, and the IVF cycle itself. Some intended parents pursue surrogacy arrangements abroad to reduce costs, but legal protections for parentage vary enormously by country and even by U.S. state. The financial and legal complexity of surrogacy is a category unto itself, and anyone considering it should budget for legal counsel as a non-negotiable line item.

Building a Realistic Budget

The most useful thing you can do before starting IVF is build a budget that accounts for a realistic number of cycles rather than assuming one cycle will work. If you are under 35 with no additional fertility factors, two to three cycles is a reasonable planning horizon. If you are over 38 or have a diagnosis like diminished ovarian reserve, planning for three to four cycles (or a move to donor eggs) is more realistic. Multiply the per-cycle cost, including medications and any planned add-ons, by your cycle estimate, then add a buffer for diagnostics, cryopreservation, and indirect expenses.

Get an itemized quote from your clinic, not just the package price. Ask specifically what is and is not included. Clinics vary in whether monitoring ultrasounds, bloodwork, anesthesia, and embryo freezing are bundled or billed separately. Compare the total out-of-pocket figure, not the base fee, when evaluating different clinics. And if you are considering a refund program, run the numbers both ways: what you would pay if you succeed on the first cycle versus what you would pay going through all included cycles. For some patients, the refund model is genuinely protective; for others, it is an expensive insurance policy against a risk that was already low.